Diagnostics Development Laboratory

 

The Diagnostics Development Laboratory (DDL) was set up in 2012 in the framework of an EFRE-founded public private partnership. Due to the increasing demand for highly sensitive and specific diagnostic methods, we devote ourselves to developing serological assays for the reliable diagnosis of tropical and emerging diseases.

With the DIN EN ISO 13485 compliant quality management system implemented, the assay development process comprises the following steps:

·       Identification of antigens

·       Expression and purification of antigens

·       Assay principle approval and assay optimization

·       Assay verification and validation

·       Production and quality control of assay components

To ensure a reliable sample supply for assay verification and validation, a reference sample bank organizing the collection, documentation and archiving of patient samples was established.

TEAM

Dr. Yang Liu
Chief Operating Officer
Dr. Christina Deschermeier
R&D Scientist
Dr. Angela Mika
R&D Scientist
Anna-Maria Mallmann
Technician
Christa Ehmen
Technician
Jürgen Sievertsen
Technician
Anne Rackow
PhD Student
 

PRODUCTS

ProductREF Number    Manual   
BLACKBOX® CCHFV IgM ELISA Kit   EL0111MDownload  
BLACKBOX® CCHFV IgG ELISA KitEL0111GDownload  

PUBLICATIONS

2017

Web page under construction

Contact

Dr. Yang Liu

Chief Operating Officer

Tel.: +49 40 42818-513
E-Mail: liu(at)bnitm.de

Dr. Christina Deschermeier

R&D Scientist

Tel.: +49 40 42818-438
E-Mail: descherm@bnitm.de

Dr. Angela Mika

R&D Scientist

Tel.: +49 40 42818-438
E-Mail: mika@bnitm.de